GMP is a system of standards ensuring that manufactured products are consistently produced and controlled to quality standards. In pharmaceutical and cell therapy contexts, GMP regulates how cells are grown, tested, and prepared for clinical use. A GMP-certified facility has passed inspection by regulatory bodies and must maintain protocols to prevent contamination, ensure sterility, and document everything.
Why it matters for cells: Stem cells are living material—they can harbour bacteria, fungi, or viruses if not handled correctly. A single contaminated cell batch could infect a patient. GMP protocols are designed to catch this before cells ever reach a patient. The process involves repeated sterility testing, microbiological assays, and continuous monitoring. It's expensive (a GMP facility costs millions to set up and maintain) but it's the standard that separates safe from unsafe operations.
What GMP covers: Facility design and cleanliness (clean rooms with controlled air pressure and particle counts); personnel training and hygiene; equipment validation (machines are tested to work correctly); material sourcing (raw materials are checked before use); manufacturing procedures (documented, step-by-step processes); quality testing (cells are tested for sterility, viability, and potency); traceability (every batch is tracked and linked to donors and recipients); and documentation (everything is recorded).
ISO 13485 is the related certification for medical device quality management. Many clinics have both GMP and ISO 13485. Having these certifications means the clinic has been independently audited and met international standards.
Key question to ask: "Are your cells manufactured in a GMP facility?" If yes, ask for proof—a GMP certificate from the relevant authority (Bulgarian health ministry, EMA, or another EU regulator). If the clinic manufactures in-house, the facility should be GMP-certified. If cells are sourced externally, the supplier should have GMP certification. Either way, you should see evidence, not just claims.
Cell banking and cryopreservation: Some clinics store extracted cells for later use ("cell banking"). If done properly, this is GMP-regulated and safe. Cells are frozen in cryoprotectant and stored in liquid nitrogen. On thaw, cells are retested before use. GMP clinics charge €500–1,000/year for storage; this covers quality oversight. If a clinic offers free or suspiciously cheap banking, question their protocols.
Non-GMP cells: Some clinics argue they don't need GMP because they expand cells "minimally" or use "closed systems." Under EU Directive 2004/23/EC, certain cell preparations are exempt from pre-authorisation if they meet manufacturing standards but aren't classified as drugs. This exemption allows clinics to deliver culture-expanded cells without running a full pharmaceutical approval pathway. However, exemption doesn't mean no standards—facilities still must meet the Directive's requirements for quality, safety, and traceability. A clinic claiming to be "outside GMP" while operating in the EU should still be compliant with Directive 2004/23/EC. Ask them to explain which regulatory framework they follow instead.
Red flag: A clinic claiming they don't need GMP or EU oversight and that this "allows them to offer better care." This is backwards. Regulatory frameworks exist to protect you.
Third-party testing: Some clinics use independent laboratories to verify cell quality. This is excellent—it means cells are tested by a neutral party, not just the clinic's own lab. If a clinic is proud of their cells, they're happy for independent validation.
Documentation you should see: A certificate of analysis (CoA) for your cells, showing test results for sterility, viability (percentage of living cells), potency (ability to perform intended function), cell count (how many cells you received), identity (which cell type), and batch traceability. Some clinics withhold this as proprietary; legitimate ones provide it, at least to you (the patient) even if not publicly.
Cell potency is subjective and depends on condition treated. For immunomodulatory therapy, potency might be measured by the cells' ability to suppress immune activation in a lab assay. For tissue repair, it might be measured by their ability to stimulate collagen production or differentiate into target tissue. Ask your clinic how they measure potency for your specific condition; vague answers suggest they haven't validated this.
Costs of GMP compliance: GMP facilities cost €2–5 million to set up. Annual compliance and audits cost €100,000–300,000. This is passed to patients in higher treatment costs. A clinic operating with lower costs might be cutting corners on quality. However, cost alone doesn't determine quality; some clinics are efficient, others are bloated.
International variation: GMP standards are harmonized across EU, FDA, and other major regulators, but implementation varies slightly. A cell therapy legal and safe in Bulgaria might not be approved in the UK (which has its own regulatory pathway post-Brexit). Ask your clinic how they account for this and whether they can support follow-up care if you're treated in Bulgaria but return to the UK.
Bottom line: GMP certification is a strong positive signal. It shows a clinic invests in quality, submits to external audit, and takes contamination risks seriously. A clinic either has GMP certification and can prove it, or it doesn't. If they can't produce evidence despite claiming GMP, that's a red flag. For safety, GMP or equivalent regulatory compliance is non-negotiable.
Sources & further reading
Educational guide; most uses are investigational — consult a qualified physician. Reviewed by the StemCellAtlas editorial team.